Back to Journals » Psychology Research and Behavior Management » Volume 17

Potential Link Between Exercise and N-Methyl-D-Aspartate Glutamate Receptors in Alcohol Use Disorder: Implications for Therapeutic Strategies

Authors Sedhom S, Hammond N, Thanos KZ, Blum K , Elman I , Bowirrat A , Dennen CA, Thanos PK

Received 17 February 2024

Accepted for publication 16 May 2024

Published 14 June 2024 Volume 2024:17 Pages 2363—2376

DOI https://doi.org/10.2147/PRBM.S462403

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Editor who approved publication: Dr Gabriela Topa



Susan Sedhom,1 Nikki Hammond,1 Kyriaki Z Thanos,1 Kenneth Blum,2,3 Igor Elman,4 Abdalla Bowirrat,3 Catherine Anne Dennen,5 Panayotis K Thanos1

1Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions (BNNLA), Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA; 2Division of Addiction Research & Education, Center for Sports, Exercise & Global Mental Health, Western University Health Sciences, Pomona, CA, USA; 3Department of Molecular Biology and Adelson School of Medicine, Ariel University, Ariel, Israel; 4Department of Psychiatry, Harvard School of Medicine, Cambridge Health Alliance, Cambridge, MA, USA; 5Department of Family Medicine, Jefferson Health Northeast, Philadelphia, PA, USA

Correspondence: Panayotis K Thanos; Kenneth Blum, Email [email protected]; [email protected]

Abstract: Alcohol use disorder (AUD) is a significant risk factor, accounting for approximately 13% of all deaths in the US. AUD not only destroys families but also causes economic losses due to reduced productivity, absenteeism, and healthcare expenses. Statistics revealing the sustained number of individuals affected by AUD over the years underscore the need for further understanding of the underlying pathophysiology to advance novel therapeutic strategies. Previous research has implicated the limbic brain regions N-methyl-D-aspartate glutamate receptors (NMDAR) in the emotional and behavioral effects of AUD. Given that aerobic exercise can modulate NMDAR activity and sensitivity to alcohol, this review presents a summary of clinical and basic science studies on NMDAR levels induced by alcohol consumption, as well as acute and protracted withdrawal, highlighting the potential role of aerobic exercise as an adjunctive therapy for AUD. Based on our findings, the utility of exercise in the modulation of reward-linked receptors and AUD may be mediated by its effects on NMDA signaling. These data support further consideration of the potential of aerobic exercise as a promising adjunctive therapy for AUD.

Keywords: exercise, alcohol use disorder, AUD, NMDA receptors, brain, reward

Introduction

Alcohol use disorder (AUD) is a major risk factor for morbidity and mortality worldwide.1 AUD refers to dysfunctional patterns of alcohol consumption that lead to clinically significant adverse symptoms of impairment or distress.2 This seems to be a self-perpetuating problem as children growing up in families afflicted with AUD tend to develop depressive disorders, low self-esteem, and high levels of neuroticism later in life.3 In the US, AUD is among the most prevalent mental health disorders.4 Research since 2008 has found that alcohol-related harm is generally increasing among adults, particularly in women, based on the US national data that analyzed trends in alcohol-related harm such as hospitalizations over time.5

A cross-sectional study utilizing the CDC WONDER database estimated an annual 25% surge in alcohol-induced overall mortality among individuals aged 25–34 and 35–44 from 2018 to 2020. These numbers are likely not considering the implications of comorbidity with synthetic opioid-induced deaths during this time, as the above report only focused on the deaths ruled to be caused by alcohol, omitting polysubstance abuse.6 Data collected from the US national panel between years 2015 to 2020 have found an upward deviation in 30-day drinking prevalence and binge drinking amongst individuals aged 25–30 during the COVID-19 pandemic. This longitudinal study had limitations regarding the validity of annual self-report data, retention of individuals throughout the study, and conflicting attribution to substance abuse.7 Approximately 15% of children (0–17 years old) live in households with one or more adults diagnosed with alcohol abuse or dependence.8

Based on these statistics, it would be important to assess the high probability of onset alcohol use, especially in children and young adults.9 The number of drinks consumed by youth (15 to 26 years of age) increases by 3% with each additional dollar per capita contributed to alcohol advertisements.10 Early onset to alcohol (specifically before the age of 18) reduces educational attainment, which indirectly hinders lifetime labor market outcomes in society.11

Tolerance contributes to Alcohol Dependence (AD) which people sustain by consuming alcohol. Studies have found an association between alcohol abuse and dependence and domestic violence, fetal alcohol syndrome, economic cost, loss of productivity, and car crashes.12 Multiple studies have shown the prevalence of participants aged 18–24 face a greater tendency to develop a tolerance for alcohol.13 In the US, 12.5% of people depend on alcohol throughout the span of their lifetime, while 3.8% of people have identified having an annual dependence on alcohol.14 Many individuals who engage in sustained alcohol consumption exhibit behaviors consistent with alcohol compulsion, which involves persistently consuming alcohol despite negative consequences. Clinical research on alcohol compulsion is limited due to ethical limitations, but studies utilizing rodent paradigms have been found to emulate brain-circuitry comparable to humans.15 Alcohol Withdrawal Syndrome (AWS), is an array of physiological symptoms that result from secession of excessive alcohol consumption, constituting a component of AUD. AWS, due to excessive use of alcohol, can lead to impaired mental stability in people. This includes the prevalence of anxiety disorders, depression, and sleep disorders.16 Symptoms of AWS can range from mild withdrawal symptoms to delirium tremens.17 Signs may arise within 24 to 48 hours of last consumption, and symptoms could arise unexpectedly in an alcohol-dependent patient or by choice. In the most drastic cases, a patient may face delirium, and/or withdrawal seizures which may be fatal.18–21 It is strongly advised that individuals seeking treatment for AUD undergo supervised detoxification due to the significant risk of severe physical symptoms during this phase. The American Society of Addiction Medicine (ASAM) recommends medication-assisted treatment to ensure a safe and medically supported transition through detoxification.21 While pharmacological intervention has a statistically significant positive effect, studies have found medication used to treat AUD fail to consistently perform better than placebo in reducing AUD symptoms. Alternative non-pharmacological therapies like facilitation groups and Cognitive Behavioral Therapy (CBT) can be used to address maladaptive behavior patterns associated with AUD. However, studies have found the effectiveness of psychological interventions for AUD to have limited generalizability beyond specific controls and are no more effective than current pharmacological options.22

From a neurobiological standpoint, alcohol’s mechanism of action is complex and involves a plethora of neurotransmitters including dopamine (DA), where even the anticipation of alcohol consumption is enough to illicit neurotransmitter signaling effects.23–28 Other neurotransmitters involved in alcohol consumption include glutamate,29–39 and γ-aminobutyric acid (GABA),26,27,40–43 as well as glycine receptors (GlyRs),44,45 serotonin46–48 and the peptide hormone vasopressin.49,50 It is well-known that opioidergic mechanisms are also linked to ethanol neurochemical induced neurological insults.51,52 Given the notable differences observed during ethanol consumption, it is worth mentioning these neurotransmitters as they may play an important role. The gut microbiome is linked to a bidirectional signaling network between the enteric nervous system (ENS) and the central nervous system (CNS), forming the gut-microbe-brain axis. The dysfunction of the gut-brain axis contributes to cognitive dysfunction and mood changes seen in AUD-induced neuropsychiatric disorders. Imbalance in intestinal flora can lead to dysfunction in the gut-limbic circuit system, involving the hippocampus, amygdala, and frontal cortex.53 The clinical manifestations of brain damage resulting from chronic alcohol use are primarily attributed to the pathophysiology stemming from thiamine deficiency. Due to the close association between alcohol consumption and thiamine deficiency, recurrent episodes of subclinical thiamine deficiency may play a role in the development of neurological conditions such as alcohol-related brain damage (ARBD), Wernicke encephalopathy (WE), and Korsakoff syndrome (KS).54

Research has revealed the profound effects that physical exercise has on neuronal proliferation, protein activation, and expression throughout the brain which includes hippocampal neurogenesis in humans.55 There is a multitude of exercise regimens that illicit different physiological and neurobiological responses. This can be addressed by considering the difference between aerobic and anaerobic physical activity. Aerobic exercise is found to enhance brain plasticity and brain-derived neurotrophic factor (BDNF) levels while anaerobic exercise may have indirect benefits on mood and cognition through overall fitness improvements.56 In older adults, aerobic exercise training correlates with improved memory function and increased hippocampal tissue volume.57 Research conducted on humans demonstrated the precise impact of aerobic exercise to increase regional brain metabolism in areas responsible for memory, motivational drive, motor processing, somatosensory processing, and cognition.58 In both humans and animals, physical activity has been found to dampen physiological and psychological responses to stressful stimuli.59 Additionally, exercise has been shown to have beneficial effects in alleviating symptoms associated with Parkinson’s disease, Alzheimer’s disease, stroke, substance use disorder (SUD), and reward deficiency syndrome.60 Feelings of euphoria can also be elicited by physical exercise through the release of endocannabinoids and opioids. Neuromodulators like brain-derived neurotrophic factor (BDNF) to be highly active due to physical activity.61 It is important to note the beneficial effects of exercise differ depending on various factors like biological sex differences, duration of physical activity, intensity of exercise, and genetic predisposition which warrants further research to explore the full potential of physical activity in mediating the effects of SUDs. Such factors impact the degree of efficacy and beneficial impacts exercise has on one individual versus the next. In addition, the various methods of evaluation and assessment of biological impacts of exercise can explain for the heterogeneity in results.60,62

Ultimately, the long-lasting negative impact AUD has demonstrated on a societal level highlights the pressing need for effective therapeutic interventions. Acknowledging the elevated recurrence of AUD despite pharmacological and behavioral therapies underscores the pressing demand for novel therapeutic strategies. Given the growing efforts instigating physical activity acting as a regulator of neurotransmitter systems and neurogenesis implicated in substance use disorders, there is an opportunity to explore the therapeutic potential of exercise on AUD. While NMDA receptors in the cerebral cortex and hippocampus garner attention in research, this review predominantly focuses on the hippocampus due to its crucial role in memory formation and the implications of AUD. It is important to recognize NMDARs role in various cognitive processes distributed across multiple brain regions, but the emphasis on the hippocampus in NMDAR research can be attributed by its disease prevalence and memory formation functions. By targeting neurobiological mechanisms and dampening the effect of alcohol induced neurotoxicity, exercise may offer a promising adjunctive therapy to complement existing treatment protocols for AUD.

The N-methyl D-aspartate receptors (NMDARs) play a major role in memory and synaptic plasticity. In the brain, NMDARs are found to be targets of alcohol consumption, although the exact action of ethanol inhibition of these receptors stands to be unclear.63 Focusing on the synaptic cleft, utilizing ethanol for acute treatment of neurons shows no effect towards the presynaptic compartment. Conversely, the post synaptic department portrayed depressed currents mediated via NMDARs due to acute exposure to ethanol.64 Contributing to suppressed NMDA activity, initial exposure to alcohol inhibits the action of glutamate on NMDAR in the hippocampus.64 One experiment looked at hippocampal neurons with a voltage clamp utilizing ethanol concentrations of 5mM to 100mM to examine NMDA receptor activity and intoxication levels. The data from this study shows ethanol concentrations increasing from 5mM to 100mM correlating with a rise of inhibition of NMDAR hippocampal neurons64 (Table 1). Studies have drawn the correlation of increased NMDAR inhibition due to high ethanol potency being related to the increased potency of ethanol intoxication in humans.39 Few studies have shown implications of ethanol-mediated-NMDA inactivity attributed to the presence of C-terminal amino acids; while others attribute this phenomenon on the phosphorylation state of NMDAR subunits.65–67 While mechanisms remain unclear, ethanol is found to limit the passage of cations through the NMDAR pore. This leads to a reduction of glutamate neurotransmission and further supports the concept of ethanol acting as a non-competitive NMDAR antagonist.68 Although the nature of mammalian ion channel functionality in response to ethanol exposure is inconclusive; there is viable proof showing the linear relationship of NMDA depressed activity due to intoxicating levels of ethanol.

Table 1 The Effects of Ethanol Consumption and Exercise on NMDA Receptors Found in the Hippocampus of Sprague-Dawley Rats

Contrasting the acute effects of ethanol on NMDARs, chronic use of alcohol is believed to trigger a compensatory mechanism by increasing levels of NMDARs in the brain.74 The extended use of ethanol contributes to the downregulation of GABAa receptors, while upregulating NMDARs involved in glutamatergic pathways.75 The neurotransmitters linked to reinforcing effects of alcohol are said to be endogenous opiates, GABA, serotonin, dopamine, and glutamate acting on NDMA receptors.76 There have been numerous studies that found chronic ethanol exposure increases expression of NMDARs in the hippocampus;77,78 medial orbitofrontal cortex;77 agranular insular cortex;79 nucleus accumbens core; central nucleus of amygdala;80 and other parts of the central nervous system.81 It is important to note this compensatory mechanism has been shown to proliferate NMDARs that deviate from the endogenous receptors. For example, research done on animal models have attributed the increase of glutamatergic activity due to chronic ethanol consumption to novel NMDARs containing GluN2A and GluN2B subunits.82 In addition, selection of alcohol-preferred rats (P rats) showed with chronic and intermittent alcohol exposure, protein levels of NR2a & NR2b increased in the nucleus accumbens core.80 Utilizing various methods of electrophysiological and biochemical techniques found chronic ethanol exposure is shown to enhance the response of NMDA stimulation in the cerebellar granule, hippocampal, and cortical neuronal cultures.83 While human studies remain limited when evaluating NMDAR composition, clinical studies in 2021 by Patel and others have put forth the initial test to consider upregulation of central striatal GluN2B subunit levels in individuals positive for familial alcohol use disorder.84 Moreover, research has found single nucleotide polymorphisms (SNPs) in the Fyn gene of humans to impact the risk and severity of AUD.85 Putting aside the effects shown in the hippocampus of rats/mice, an experiment conducted showed the effects chronic ethanol exposure may have on NMDARs found in the posterior cingulate cortex (PCC). Results show juvenile rats experiencing an increase in ethanol sensitivity by the neurons found in the PCC. This questions the sheer efficacy of learning and memory in young individuals who chronically drink alcohol.86

Excessive glutamatergic neurotransmission is known to be correlated with acute withdrawal syndrome (AWS) and a signaling factor for dependence-related neuroplasticity. One study showed a significant increase in glutamate levels during withdrawal in prefrontal regions of the brain, in addition to an increased glutamate/glutamine ratio.87 Withdrawal symptoms faced by abstinence from chronic alcohol intake may be related to increased synthesis of glutamate and decreased synthesis of GABA in the brain.88 Hyperactivity of the glutamatergic system due to alcohol withdrawal and the use of drugs impacting NMDARs has been linked to evident aggressive behavior.25 In addition, AWS is greatly related to withdrawal-induced anxiety due enhanced function of NMDA receptors.89 The protein levels for NR2A and NR2B subunits were elevated in the CA1 region of hippocampal slices from rats facing withdrawal from a chronic intermittent ethanol treatment.90 In addition, alcohol withdrawn rats displayed downregulation of NR2B mRNA in the hippocampal region of the brain.91 This increase in protein levels yet decrease in mRNA expression of the NR2B can be due to the initial upregulation of the mRNA when chronic ethanol exposure is taking place. Studies have found neurons perceptive to glutamatergic excitotoxicity after facing a period of ethanol withdrawal. This is further understood by NMDAR activity since the use of MK801 (NMDA antagonist) during periods of abstinence is found to decrease ethanol-induced neurotoxicity.64

Effects of Exercise on Alcohol and Drug Use

Effects of Exercise on Drug Use

The number of studies evaluating the mechanisms of exercise reward pathways and the therapeutic effects against substance use is growing. For instance, aerobic exercise has been associated with diminished heroin craving in humans, and voluntary physical activity has been effective in reducing heroin-seeking behavior in rats, revealing the potential implications of voluntary physical exercise and therapeutic methods for heroin dependence in a clinical setting.92,93 Additionally, studies have demonstrated that treadmill exercise can induce a brain glucose response in regions relevant to addiction behaviors, although the scope of some studies may be limited to specific conditions or populations.62 Randomized controlled trials have linked acute moderate to vigorous-intensity exercise to decreased drug cravings in individuals with SUDs, highlighting the potential protective role of exercise against drug use.72 While past research has explored exercise’s impact on drug relapse, recent systemic reviews have emphasized exercise as a valuable component in SUD prevention, reduction, treatment, and recovery efforts. Overall, exercise has shown promise in alleviating symptoms of anxiety and increasing abstinence rates among individuals facing substance use disorders.94–99

Effects of Exercise on Alcohol Use

Research has revealed the profound effects that physical exercise has on neuronal proliferation, protein activation, and expression throughout the brain. Physical exercise is found to stimulate adult hippocampal neurogenesis in humans. This growth avoids intrusion between newly learned memories and established ones.100,101 Aerobic exercise is found to elicit a “good stress” response throughout the nervous system. After the hypothalamic-pituitary-adrenal axis is stimulated, elevated cortisol levels in the circulatory system can inhibit the hypothalamus and pituitary gland through receptors found on the medial prefrontal cortex. This circuit reduces the excitation of the amygdala due to a stress response.102 Studies have found acute physical activity to modulate levels of neurotransmitters like serotonin, norepinephrine, and dopamine. In addition, feelings of euphoria can be elicited by physical exercise through release of endocannabinoids and opioids. Neuromodulators like brain-derived neurotrophic factor (BDNF) can be highly active due to physical activity.103

Exercise regimens are increasingly being used as a means of intervention for individuals facing AUD.104 A systematic review published in the United Kingdom aimed to discuss the literature available pertaining to the implications of physical activity in conjunction with alcohol and drug use across the lifespan. Findings therein point to exercise intervention in alcohol treatment being considered the most well-researched subject matter compared to prevention and reduction of alcohol use. In addition, meta-analysis determined exercise intervention posing no risk to alcohol and drug use. The various studies evaluated postulate the effects of physical activity being utilized for intervention and having a dose-dependent response to subjects participating in the research. This poses the idea of evaluating individuals seeking treatment based on basal physical activity levels, an (accompanied with an) acclimated level of drug use.69 A randomized controlled trial evaluated the change in alcohol consumption in individuals aged 18–75 diagnosed with AUD who participated in exercise as a sole method of intervention, versus telephone counselling with a psychologist or a behavioral scientist. After the 12-week study was complete, results show aerobic exercise to decrease weekly alcohol consumption in comparison with usual treatment (ie telephone counselling). This particular study is limited to including participants seeking non-pharmacological treatment for AUD in which they would take part in a novel exercise protocol. The results can be dependent on the motivation to seek lifestyle changes and the ability to acquire access to exceeding treatment options. Nonetheless, this study did take into account basal physical activity of participants, excluding members who were already participating in regular physical activity.105 A meta-analysis conducted in 2017 explored the possible health outcomes of exercise on individuals with AUD. Results show a significant decrease in depressive symptoms and improved physical fitness.104 While one may be inclined to agree with the favorable effect of physical activity in preventing alcohol and other drug use, it is crucial to acknowledge the limited clinical data available to support this statement. According to Thompson and others, the area of using physical activity to prevent alcohol and other drug use is relatively under-researched, with only five identified studies conducted in the USA.69 When interpreting mechanisms on a micro level, glial cells are found throughout the adult nervous system and contribute to supportive functions of neurons that are essential to life. Alcohol exposure can result in a loss of glial cells which can allow neurodegeneration to occur. Research has found consistent data supporting the trend of increasing the release of tropic factors by microglia via physical activity.106,107

Effects of Exercise on NMDA Receptors

The glutamate system is crucial for processing information in various neural networks found in regions like the hippocampus or caudate-putamen.108,109 Proton magnetic resonance spectroscopy (MRS) before and after intense exercise show signals for glutamate increasing in the anterior cingulate cortex, as well as the visual cortex.110 Past studies looked into intervention methods for the highly active corticostriatal glutamatergic neurotransmission correlating to Parkinson’s Disease. Physical activity was found to decrease the excessive glutamate activity by modifying metabotropic receptors such as NMDA and AMPA; all while not directly impacting dopamine levels.111 Research done pertaining exercise restoring endogenous glutamatergic systems is important to consider when discussing the therapeutic methods used towards SUD intervention.

The literature devoted to evaluating the effects physical activity has on NMDARs focusses heavily on long-term potentiation (LTP) in both clinical and preclinical studies. A systematic review found studies which show acute and chronic engagement of physical activity having a robust effect on LTP in the brain.112–115 There are several contributing growth factors and signaling mechanisms that play a pivotal role in the activity of NMDARs during exercise. The activation of NMDARs due to physical activity attributes to the enhancement of BDNF-mediated plasticity via signaling cascades which plays a huge role in the cognitive benefits derived from exercise.60

Evaluating subunit expression and relative activity of neuronal receptors during physical activity is found to be a prominent method of evaluation when assessing the beneficial effects of exercise against drug addiction. Research conducted to evaluate the effects of chronic aerobic exercise found change in only GABA(a) receptor activity compared to mu-opioid receptors.116 In addition, one study attempted to assess the alterations of the mesolimbic dopamine pathway due to exercise, and how this may explain the changes in drug-seeking behavior. Results showed exercise rats displaying changes of dopamine-receptor binding in the ventral striatum and subregions of the dorsal striatum compared to sedentary rats. This may contribute to the neuronal mechanism responsible for reducing drug-seeking behavior. This study did not consider rodent sex differences that can ultimately impact dopamine-related measures during the experiment. Nonetheless, this type of study can allow a hypothesis that mechanistic alterations due to exercise that can serve a therapeutic advantage towards SUD.117 We can also assess neurobiological receptors and systems to rule out possible mechanisms from physical activity that attribute to therapeutic methods against SUD. For example, the CB1 receptor plays an essential role in endocannabinoid signaling throughout the nervous system. One study evaluated CB1 receptor levels in the brains of chronic aerobic exercise rats. Results showed no significant alteration of CB1 receptor levels in exercise subjects. So studies utilizing the same exercise regimen can discredit the involvement of CB1-receptor level modulation in decreased drug seeking behavior.118 The upregulation of the NMDA NR2B subunit in the hippocampus of rats was shown following low-intensity treadmill running for 8 weeks.119 Long-term exercise protocols have been found to increase NMDA subunit expression, but acute high-intensity exercise (no longer than 30 minutes) does not induce the same effect.

Implications of NMDA Receptor Modulation of AUD Through Exercise

Effects of Exercise on AUD

There are several pharmacological therapeutic approaches of treating AUD that are proven to be successful for some. These include disulfiram, naltrexone, and acamprosate, which is believed to act as a noncompetitive NMDAR blocker.71,120 In addition, non-pharmacological treatments like cognitive-behavioral therapy been effective in treating AUD.70 Unfortunately, rates of relapse are still substantially high, which is concerning considering that almost 15 million Americans suffer from AUD.73 In general, physical exercise can provide gratifying emotional states to participating subjects. Exercise can mediate alcohol withdrawal, improve self-efficacy104 and reduce alcohol dependency, as well as decrease relapse in subjects.121

Neurobiological Mechanisms

Neurogenesis has been shown in the hippocampus of exercise subjects.122 Several molecular neurotrophic and growth factors come into play when investigating these effects of physical activity on the brain. This includes insulin-like growth factor-1 (IGF-1);119 neurotrophin-3 (NT-3);123 brain-derived neurotrophic factor (BDNF);124 fibroblast growth factor 2 (FGF-2);125 and vascular endothelial growth factor (VEGF).126 Many studies looking into the protective effects of exercise against neurodegenerative diseases found IGF-1 to be responsible for broad c-Fos expression in neurons, in addition to improved memory performance after physical activity.119 VEGF has shown to be a necessary component of adult hippocampal exercise-induced neurogenesis.126 BDNF is considered to play an essential role in cognitive ability since low levels of it are recorded in patients suffering from neurodegenerative diseases.126,127 Equally critical are the signaling pathways governed by these growth factors. Shifting focus to the hippocampus, we can gain insight into the neurobiological signal transduction during voluntary physical exercise. Such understanding extends to how physical activity influences AUD at both macro and micro levels. This pertains to the overall behavioral changes seen in clinical trials, to the mechanistic alterations that allow an individual to reap the benefits of exercise. The hippocampus has been extensively evaluated in research pertaining to AUD, which is relevant when evaluating the cause of impaired processing and memory formation displayed during intoxication.128 These findings support examining NMDA receptor modulations pertaining to the neurobiological mechanisms within the hippocampus and the effects induced by alcohol exposure.

NMDA Receptor Effects in Different Alcohol States

Acute Exposure

Generally, research supports acute exposure to alcohol having a debilitating effect on NMDARs (Table 1). Specifically, a decrease in NMDAR function in hippocampal neurons due to the acute exposure to ethanol has been described.129 In contrast, some studies have found evidence of increased NMDAR function due to acute ethanol exposure. Nonetheless, these studies acknowledge acute ethanol-induced inhibition of NMDARs with subsequent increase in receptor function due to NR2B tyrosine residue phosphorylation. Therefore, ethanol intake highlights the acute tolerance of hippocampal NMDARs due to phosphorylation.130 Alternatively, the NR2A subunit and its associated protein kinases exhibit the opposite effect of NR2B due to ethanol exposure.131 This study determined acute ethanol exposure indirectly prevents phosphorylation of the NR2A subunit.132 Nonetheless, the compartmentalization of NR2B exemplifies a model of plasticity of these NMDARs that can determine the degree of sensitivity set forth if ethanol exposure becomes chronic.133,134 Acute ethanol exposure is found to modulate motivational systems that ultimately allow the positive reinforcing effects of alcohol to occur.135 Overall, research has shown in vitro analysis of acute ethanol exposure to decrease the activity or inhibit the functionality of NMDARs in various regions of the brain.

Chronic Exposure

Chronic alcohol exposure studies have reported a decrease in NMDA receptor function.64,86,136,137 One key point is the variability of chronic exposure for ethanol exposure in vitro and in vivo varies. Historically, an increase in receptor subunit levels (NR1 and NR2A-B) in the hippocampus of rats was found following chronic ethanol treatment (Table 1). This can be an adaptation of neuronal cells in order to maintain homeostasis being that NMDARs initially decrease functionality due to acute exposure. The composition of these receptors plays a critical role in ethanol. Furthermore, chronic ethanol exposure tends to increase NMDAR synaptic transmission via elevated calcium influx.137 The enhanced function of these receptors is correlated to the novel composition of NMDAR subunits due to alcohol exposure. In order to study the implications of alcohol compulsion and NMDARs, researchers must consider the ethical limitations of a clinical study model that would promote continued intake of alcohol in the face of negative consequences. Nonetheless, the nucleus accumbens of rodents is a known player in drug-motivated behavior. Past research has revealed active non- canonical NMDARs at hyperpolarized potentials within the nucleus accumbens of rodents play a critical role in compulsive-like alcohol behavior.15,138 It has also been shown that inhibiting said NMDARs selectively reduces compulsion-like alcohol drinking in rodents.139 This data coincides with the limited research on humans that implicate NMDARs in alcohol craving with treatment-seeking subjects.140 Ultimately, juxtaposing human and rodent studies reveal similarities of clinical pharmacological compounds that entail decreased ethanol consumption.15

Alcohol Withdrawal

Pertaining to the alcohol withdrawal and the effect it has on NMDARs, there seems to be a lasting effect of increased NMDAR expression/protein levels. The elevated function/activity of NMDARs observed can lead to high release of glutamate in the hippocampus leading to high Ca2+ concentrations.141 Nonetheless, the impact NMDAR hyperexcitability may have on an individuals’ physiological state correlates to epileptic seizures,142 increased craving, and dysphoria.143 With this in mind, we can evaluate the effects exercise has on NMDA subunit composition and function in the hippocampus and see if intervention is possible.

Exercise and NMDA Receptor Adaptations

When it comes to exercise, conflicting results are found for the NR2A and NR2B expression in the hippocampus. Voluntary wheel running has shown to increase NR2B expression in rodents, while resistance wheel running increases NR2A expression in the hippocampus of rats (Table 1). The study dedicated to evaluating high-intensity exercise on the NMDAR composition in Sprague-Dawley rats found initial elevated expression of both NR2A and NR2B subunits.122 Although many studies may reveal conflicting results, it is evident to see the variation of subunit expression due to aerobic exercise (voluntary wheel running) versus anaerobic exercise (resistance training). These results can be compared to the use of pharmacological antagonists for the NR2B subunit to prevent the neurotoxic effect due to ethanol withdrawal. An NR2A antagonist was shown to prevent LTD in running mice but not in sedentary mice, showing an increase in involvement of the NR2A subunit of the hippocampus on neuronal plasticity.19 Solomon and others found no change in subunit protein levels but did see a predominant increase in NR1 and NR2B hippocampal phosphorylation.144 This phenomenon shows the capability of exercise altering protein kinase activity to impact receptor phosphorylation. We have provided examples in terms of NMDAR subunit contribution to LTP/LTD. This is not to say results are absolute, being that numerous studies contribute both NR2A and NR2B subunits to LTP and LTD.145,146 Although there are studies done on receptor alterations due to exercise, most look into the impact it has on memory and recognition, which serves a benefit to research in LTP/LTD.

Implications for AUD Treatment

Recent research indicates that prediabetes, a condition characterized by impaired glucose regulation, may be analogous to reward dysregulation, the early stages of addiction.147 To begin with, impaired central and peripheral insulin sensitivity, a hallmark of prediabetes, may contribute to worsened addiction, as the brain’s reward pathways rely heavily on glucose and insulin signaling.148 NMDAR in the limbic brain regions play a critical role in the emotional, behavioral, and clinical aspects of addiction149,150 while abnormal insulin signaling affects NMDAR activity,151,152 leading to changes in neurotransmission and further contributing to the development of addiction.149,153,154 Furthermore, chronic alcohol use results in insulin resistance, exacerbating the negative effects of impaired glucose regulation on NMDAR signaling.155–157 This may be reflected in the development of AUD and other addictive behaviors. Exercise has been proposed as a potential adjunctive therapy for addiction, including AUD.158 Exercise is known to modulate NMDAR activity and sensitivity to alcohol, potentially mitigating the effects of impaired insulin signaling on addiction development. Further research is certainly needed to better define the heuristic value of exercise in the modulation of reward-linked receptors and addiction and its overall position within the therapeutic armamentarium for patients with addictive disorders.

Conclusion

Previous research has described the alterations of NMDARs in the cerebral cortex and hippocampus, this review prioritizes the hippocampus because of its pivotal role in memory formation and its direct ramifications for AUD. This paper outlined how NMDA receptors are influenced differently at various stages of ethanol use. Acute exposure generally inhibits NMDAR function, leading to neuroadaptive changes. Chronic exposure can cause an increase in NMDA receptor subunit levels, altering synaptic transmission. During withdrawal, increased NMDAR expression may contribute to hyperexcitability. Exercise has shown promise in modulating these effects by influencing NMDA subunit composition and function, potentially mitigating the impact of ethanol use on NMDAR signaling. Compared to pharmacological studies, research on the impact of physical activity on these receptors is scarce. It is difficult to say which variation of physical activity (anaerobic versus aerobic) would lead to better outcomes of treatment if we solely evaluate subunit composition of NMDARs. Nonetheless, we know the activity of these receptors plays an important role in neuroplasticity and learning and memory, which of course are impacted by AUD. Based on the information highlighted in this review, aerobic exercise appears to have a more direct and comprehensive impact on the neurobiological, psychological, and physiological factors relevant to AUD and addiction recovery. This suggests a potential hypothesis that aerobic exercise could serve as an adjunct intervention technique for AUD treatment. Preclinical studies can explore not only the effects aerobic exercise has on NMDAR activity and modulation, but also what can be looked into in terms of these receptors and sensitivity to ethanol. Further research is warranted to fully assess the potential of exercise as a therapeutic intervention technique for AUD.

Funding

This research received no external funding.

Disclosure

Professor Kenneth Blum reports personal fees from VNI, Sunder Foundation, PEAKLOGIC, ADVANCED SPINECLINIC TUCSON AZ, ELECTRONIC WAVEFORM LABS; president of SYNAPATAMINE INC. The authors report no other conflicts of interest in this work.

References

1. Park SH, Kim DJ. Global and regional impacts of alcohol use on public health: emphasis on alcohol policies. Clin Mol Hepatol. 2020;26(4):652–661. doi:10.3350/cmh.2020.0160

2. Cheng HG, Phillips MR, Li X, et al. Co-occurrence of DSM-IV mental disorders and alcohol use disorder among adult Chinese males. Psychological Medicine. 2017;47(16):2811–2822. doi:10.1017/S0033291717001337

3. Waligórska A, Warońska W, Dymecka J, Filipkowski J. Personality, self-esteem, and depression in people from families with an alcohol-related problems. Alcohol Drug Addict. 2022;35(1):31–42. doi:10.5114/ain.2022.117426

4. Witkiewitz K, Litten R, Leggio L. Advances in the science and treatment of alcohol use disorder. Sci Adv. 2019;5(9):eaax4043. doi:10.1126/sciadv.aax4043

5. Esser MB, Leung G, Sherk A, et al. Estimated deaths attributable to excessive alcohol use among US adults aged 20 to 64 years, 2015 to 2019. JAMA Network Open. 2022;5(11):e2239485. doi:10.1001/jamanetworkopen.2022.39485

6. Maleki N, Yunusa I, Karaye IM. Alcohol-induced mortality in the USA: trends from 1999 to 2020. Int J Ment Health Addict. 2023. doi:10.1007/s11469-023-01083-1

7. Patrick ME, Terry-McElrath YM, Miech RA, Keyes KM, Jager J, Schulenberg JE. Alcohol use and the COVID-19 pandemic: historical trends in drinking, contexts, and reasons for use among US adults. Soc Sci Med. 2022;301:114887. doi:10.1016/j.socscimed.2022.114887

8. Ohannessian CM, Vannucci A. Parent problem drinking trajectory classes predict anxiety in adolescence and emerging adulthood. J Affective Disord. 2022;308:577–586. doi:10.1016/j.jad.2022.04.104

9. Morrison CN, Byrnes HF, Miller BA, Wiehe SE, Ponicki WR, Wiebe DJ. Exposure to alcohol outlets, alcohol access, and alcohol consumption among adolescents. Drug Alcohol Depend. 2019;205:107622. doi:10.1016/j.drugalcdep.2019.107622

10. Hosseinichimeh N, MacDonald R, Li K, et al. Mapping the complex causal mechanisms of drinking and driving behaviors among adolescents and young adults. Soc Sci Med. 2022;296:114732. doi:10.1016/j.socscimed.2022.114732

11. Peña S. Socioeconomic differences in alcohol use, disorders and harm: Exploring the Alcohol Harm Paradox [Dissertationes Scholae Doctoralis]. Ad Sanitatem Investigandam Universitatis Helsinkiensis; 2021.

12. Todd J. Changes in Student Attitudes and Beliefs After Sbirt Training. Indiana State University; 2020.

13. Marmet S, Studer J, Bertholet N, Grazioli VS, Daeppen J-B, Gmel G. Interpretation of DSM-5 alcohol use disorder criteria in self-report surveys may change with age. A longitudinal analysis of young Swiss men. Addict Res Theory. 2019;27(6):489–497. doi:10.1080/16066359.2018.1547817

14. Munivel K. A Study of Neurocognitive Functioning in Euthymic Bipolar Patients with and without Alcohol Dependence. Chennai: Madras Medical College; 2020.

15. De Oliveira Sergio T, Darevsky D, Kellner J, et al. Sex- and estrous-related response patterns for alcohol depend critically on the level of compulsion-like challenge. Prog Neuro Psychopharmacol Biol Psychiatry. 2024;133:111008. doi:10.1016/j.pnpbp.2024.111008

16. Farheen SA, Chhatlani A, Tampi RR. Anticonvulsants for alcohol withdrawal: a review of the evidence. Curr Psychiatry. 2021;20(2):19. doi:10.12788/cp.0094

17. Jesse S, Bråthen G, Ferrara M, et al. Alcohol withdrawal syndrome: mechanisms, manifestations, and management. Acta neurol Scand. 2017;135(1):4–16. doi:10.1111/ane.12671

18. Csomós-Pribék IK. Withdrawal syndrome and comorbidity in alcohol use disorder: focusing on anxiety. [Doctoral dissertation]. Hungary: Szegedi Tudomanyegyetem; 2022.

19. Nangeroni S. Art therapy interventions that facilitate improved self-esteem for an adult with depression and substance abuse; 2018.

20. Vergés A, Lee MR, Martin CS, et al. Not all symptoms of alcohol dependence are developmentally equivalent: implications for the false-positives problem. Psychol Addict Behav. 2021;35(4):444–457. doi:10.1037/adb0000723

21. Weststrate TR. A Brief Acceptance and Commitment Therapy Protocol for Alcohol Withdrawal Symptoms: A Randomized Controlled Trial for Inpatient Detoxification Patients [Ph.D.]. Ann Arbor: Western Michigan University; 2022.

22. Lohoff FW. Targeting unmet clinical needs in the treatment of alcohol use disorder. Front Psychiatry. 2022;13:767506. doi:10.3389/fpsyt.2022.767506

23. Ngui HHL, Kow ASF, Lai S, Tham CL, Y-C H, Lee MT. Alcohol withdrawal and the associated mood disorders—a review. Int J Mol Sci. 2022;23(23):14912. doi:10.3390/ijms232314912

24. Weigand E. Influence of the Neutral Sphingomyelinase on Central Monoaminergic Signaling in a Model of Voluntary Alcohol Consumption [Doctoral dissertation]. Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU); 2022.

25. Tobore TO. On the neurobiological role of oxidative stress in alcohol-induced impulsive, aggressive and suicidal behavior. Subst Use Misuse. 2019;54(14):2290–2303. doi:10.1080/10826084.2019.1645179

26. Roman MR. Mechanisms of Alcohol-Induced Sleep Dysregulation in Drosophila Melanogaster. Puerto Rico: University of Puerto Rico, Rio Piedras; 2022.

27. Halverstadt BA. Using fecal microbial transfer to alter drinking behavior in a rat model of alcoholism and correlations with dopamine receptor expression; 2022.

28. Gleich T, Spitta G, Butler O, et al. Dopamine D2/3 receptor availability in alcohol use disorder and individuals at high risk: towards a dimensional approach. Addict Biol. 2021;26(2):e12915. doi:10.1111/adb.12915

29. Jamal M, Ito A, Tanaka N, Miki T, Ameno K, Kinoshita H. High ethanol and acetaldehyde inhibit glutamatergic transmission in the hippocampus of Aldh2-Knockout and C57BL/6N mice: an in vivo and ex vivo analysis. Neurotox Res. 2020;37(3):702–713. doi:10.1007/s12640-020-00180-6

30. Alasmari F, Goodwani S, McCullumsmith RE, Sari Y. Role of glutamatergic system and mesocorticolimbic circuits in alcohol dependence. Prog Neurobiol. 2018;171:32–49. doi:10.1016/j.pneurobio.2018.10.001

31. Stroebel D, Mony L, Paoletti P. Glycine agonism in ionotropic glutamate receptors. Neuropharmacology. 2021;193:108631. doi:10.1016/j.neuropharm.2021.108631

32. Gaidin SG, Zinchenko VP, Teplov IY, Tuleukhanov ST, Kosenkov AM. Epileptiform activity promotes decreasing of Ca2+ conductivity of NMDARs, AMPARs, KARs, and voltage-gated calcium channels in Mg2+-free model. Epilepsy Res. 2019;158:106224. doi:10.1016/j.eplepsyres.2019.106224

33. Sibarov DA, Poguzhelskaya EE, Antonov SM. Downregulation of calcium-dependent NMDA receptor desensitization by sodium-calcium exchangers: a role of membrane cholesterol. BMC neuro. 2018;19(1). doi:10.1186/s12868-018-0475-3

34. Q-Q L, Chen J, Hu P, et al. Enhancing GluN2A-type NMDA receptors impairs long-term synaptic plasticity and learning and memory. Mol Psychiatry. 2022;27(8):1–11.

35. Wang W-T, Lee P, Hui D, Michaelis EK, Choi I-Y. Effects of ethanol exposure on the neurochemical profile of a transgenic mouse model with enhanced glutamate release using in vivo 1H MRS. Neurochem Res. 2019;44(1):133–146. doi:10.1007/s11064-018-2658-9

36. Upaganlawar A, Ramesh S, Jones E, Suppiramaniam V, Moore T, Dhanasekaran M. Alcohol pharmacology and pharmacotherapy of alcoholism. In: Advances in Neuropharmacology. Apple Academic Press; 2020:417–446.

37. Zuidema MR. Discriminative Stimulus Effects of Gabapentin. Northern Michigan University; 2018.

38. Jung ME, Mallet RT. Intermittent hypoxia training: powerful, non-invasive cerebroprotection against ethanol withdrawal excitotoxicity. Respir Physiol Neurobiol. 2018;256:67–78. doi:10.1016/j.resp.2017.08.007

39. Bönisch H, Fink K, Malinowska B, Molderings G, Schlicker E. Serotonin and beyond—A tribute to Manfred Göthert (1939–2019). Naunyn-Schmiedeberg’s Arch Pharmacol. 2021;394(9):1829–1867. doi:10.1007/s00210-021-02083-5

40. Solinas M, Belujon P, Fernagut PO, Jaber M, Thiriet N. Dopamine and addiction: what have we learned from 40 years of research. J Neural transm. 2019;126(4):481–516. doi:10.1007/s00702-018-1957-2

41. Gatta E, Camussi D, Auta J, Guidotti A, Pandey SC. Neurosteroids (allopregnanolone) and alcohol use disorder: from mechanisms to potential pharmacotherapy. Pharmacol Ther. 2022;240:108299.

42. Ochi R, Ueno F, Sakuma M, et al. Patterns of functional connectivity alterations induced by alcohol reflect somatostatin interneuron expression in the human cerebral cortex. Sci Rep. 2022;12(1). doi:10.1038/s41598-022-12035-5

43. Floris G, Asuni GP, Talani G, et al. Increased voluntary alcohol consumption in mice lacking GABAB(1) is associated with functional changes in hippocampal GABAA receptors. Front Behav Neurosci. 2022;16. doi:10.3389/fnbeh.2022.893835

44. Fares A. Effects of Cannabis Alone and combined with alcohol on simulated driving; 2022.

45. Sever R. The effects of historical alcohol use on neuropsychological functioning in older adults following a traumatic brain injury; 2019.

46. Ferguson LB. Alcohol use disorders: transcriptomic and bioinformatic approaches; 2018.

47. Müller CP, Schumann G, Kornhuber J, Kalinichenko LS. The role of serotonin in alcohol use and abuse. In: Handbook of Behavioral Neuroscience. Vol. 31. Elsevier; 2020:803–827.

48. Fu R, Mei Q, Shiwalkar N, et al. Anxiety during alcohol withdrawal involves 5-HT2C receptors and M-channels in the lateral habenula. Neuropharmacology. 2020;163:107863. doi:10.1016/j.neuropharm.2019.107863

49. Koob GF, Dantzer R. Drug addiction: hyperkatifeia/negative reinforcement as a framework for medications development. Pharmacol Rev. 2021;73(1):163–201. doi:10.1124/pharmrev.120.000083

50. Harper KM, Knapp DJ, Criswell HE, Breese GR. Vasopressin and alcohol: a multifaceted relationship. Psychopharmacology. 2018;235(12):3363–3379. doi:10.1007/s00213-018-5099-x

51. Blum K, Elston SF, DeLallo L, Briggs AH, Wallace JE. Ethanol acceptance as a function of genotype amounts of brain [Met]enkephalin. Proc Natl Acad Sci U S A. 1983;80(21):6510–6512. doi:10.1073/pnas.80.21.6510

52. Blum K, Briggs AH, Elston SF, DeLallo L, Sheridan PJ, Sar M. Reduced leucine-enkephalin--like immunoreactive substance in hamster basal ganglia after long-term ethanol exposure. Science. 1982;216(4553):1425–1427. doi:10.1126/science.7089531

53. Li X, Chen L-M, Kumar G, et al. Therapeutic interventions of gut-brain axis as novel strategies for treatment of alcohol use disorder associated cognitive and mood dysfunction. Front Neurosci. 2022;16:820106.

54. Zahr NM, Kaufman KL, Harper CG. Clinical and pathological features of alcohol-related brain damage. Nat Rev Neurol. 2011;7(5):284–294. doi:10.1038/nrneurol.2011.42

55. Saraulli D, Costanzi M, Mastrorilli V, Farioli-Vecchioli S. The long run: neuroprotective effects of physical exercise on adult neurogenesis from youth to old age. Curr Neuropharmacol. 2017;15(4):519–533. doi:10.2174/1570159X14666160412150223

56. Zhang K, Jan Y-K, Liu Y, et al. Exercise intensity and brain plasticity: what’s the difference of brain structural and functional plasticity characteristics between elite aerobic and anaerobic athletes? Front Human Neurosci. 2022;16. doi:10.3389/fnhum.2022.757522

57. Kovacevic A, Fenesi B, Paolucci E, Heisz JJ. The effects of aerobic exercise intensity on memory in older adults. Appl Physiol Nutr Metab. 2020;45(6):591–600. doi:10.1139/apnm-2019-0495

58. Hanna C, Hamilton J, Arnavut E, Blum K, Thanos PK. Brain mapping the effects of chronic aerobic exercise in the rat brain using FDG PET. J Pers Med. 2022;12(6):860. doi:10.3390/jpm12060860

59. Robison LS, Alessi L, Thanos PK. Chronic forced exercise inhibits stress-induced reinstatement of cocaine conditioned place preference. Behav Brain Res. 2018;353:176–184. doi:10.1016/j.bbr.2018.07.009

60. Swenson S, Blum K, McLaughlin T, Gold MS, Thanos PK. The therapeutic potential of exercise for neuropsychiatric diseases: a review. J Neurol Sci. 2020;412:116763. doi:10.1016/j.jns.2020.116763

61. Di Liegro CM, Schiera G, Proia P, Di Liegro I. Physical activity and brain health. Genes. 2019;10(9):720. doi:10.3390/genes10090720

62. Hanna C, Hamilton J, Blum K, Badgaiyan RD, Thanos PK. Exercise modulates brain glucose utilization response to acute cocaine. J Pers Med. 2022;12(12):1976. doi:10.3390/jpm12121976

63. Holmgren E, Wills T. Regulation of glutamate signaling in the extended amygdala by adolescent alcohol exposure. Int Rev Neurobiol. 2021;160:223–250.

64. Mira RG, Tapia-Rojas C, Pérez MJ, et al. Alcohol impairs hippocampal function: from NMDA receptor synaptic transmission to mitochondrial function. Drug Alcohol Depend. 2019;205:107628. doi:10.1016/j.drugalcdep.2019.107628

65. Ron D, Wang J. The NMDA receptor and alcohol addiction. In: Van Dongen AM, editor. Biology of the NMDA Receptor. Frontiers in Neuroscience. Boca Raton (FL): CRC Press; 2009.

66. Ariwodola OJ, Crowder TL, Grant KA, Daunais JB, Friedman DP, Weiner JL. Ethanol modulation of excitatory and inhibitory synaptic transmission in rat and monkey dentate granule neurons. Alcoholism. 2003;27(10):1632–1639. doi:10.1097/01.ALC.0000089956.43262.17

67. Alvestad RM, Grosshans DR, Coultrap SJ, Nakazawa T, Yamamoto T, Browning MD. Tyrosine dephosphorylation and ethanol inhibition of N-Methyl-d-aspartate receptor function. J Biol Chem. 2003;278(13):11020–11025. doi:10.1074/jbc.M210167200

68. Franco D. Early-Life Ketamine Exposure Attenuates the Rewarding Properties of Ethanol in Adolescent Sprague-Dawley Rats. Long Beach: California State University; 2019.

69. Thompson TP, Horrell J, Taylor AH, et al. Physical activity and the prevention, reduction, and treatment of alcohol and other drug use across the lifespan (The PHASE review): a systematic review. Ment Health Phys Act. 2020;19:100360. doi:10.1016/j.mhpa.2020.100360

70. Choi BY, Lee SH, Choi HC, et al. Alcohol dependence treating agent, Acamprosate, prevents traumatic brain injury-induced neuron death through vesicular zinc depletion. Transl Res. 2019;207:1–18. doi:10.1016/j.trsl.2019.01.002

71. Kong M, Kulasekera K, McClain CJ, et al. An assessment of alcohol use disorder and treatment utilization among medicaid beneficiaries in Kentucky; 2022.

72. Ellingsen MM, Clausen T, Johannesen SL, Martinsen EW, Hallgren M. Effects of acute exercise on drug craving in adults with poly-substance use disorder. A randomized controlled trial. Mental Health Phys Act. 2021;21:100423. doi:10.1016/j.mhpa.2021.100423

73. Joseph LJ, Kelley-Romano S. Women of dignity and grace. In: Strategic Interventions in Mental Health Rhetoric. Routledge; 2022.

74. Carzoli KL, Sharfman NM, Lerner MR, Miller MC, Holmgren EB, Wills TA. Regulation of NMDA receptor plasticity in the BNST following adolescent alcohol exposure. Front Cell Neurosci. 2019;13:440. doi:10.3389/fncel.2019.00440

75. Day E, Daly C. Clinical management of the alcohol withdrawal syndrome. Addiction. 2022;117(3):804–814. doi:10.1111/add.15647

76. McColl ER, Piquette‐Miller M. SLC neurotransmitter transporters as therapeutic targets for alcohol use disorder: a narrative review. Alcoholism. 2020;44(10):1965–1976. doi:10.1111/acer.14445

77. Naassila M, Pierrefiche O. GluN2B subunit of the NMDA receptor: the keystone of the effects of alcohol during neurodevelopment. Neurochem Res. 2019;44(1):78–88. doi:10.1007/s11064-017-2462-y

78. Hughes BA, O’Buckley TK, Boero G, Herman MA, Morrow AL. Sex- and subtype-specific adaptations in excitatory signaling onto deep-layer prelimbic cortical pyramidal neurons after chronic alcohol exposure. Neuropsychopharmacology. 2021;46(11):1927–1936. doi:10.1038/s41386-021-01034-1

79. Bird CW, Candelaria-Cook FT, Magcalas CM, et al. Moderate prenatal alcohol exposure enhances GluN2B containing NMDA receptor binding and ifenprodil sensitivity in rat agranular insular cortex. PLoS One. 2015;10(3):e0118721. doi:10.1371/journal.pone.0118721

80. Obara I, Bell RL, Goulding SP, et al. Differential effects of chronic ethanol consumption and withdrawal on homer/glutamate receptor expression in subregions of the accumbens and amygdala of P rats. Alcohol Clin Exp Res. 2009;33(11):1924–1934. doi:10.1111/j.1530-0277.2009.01030.x

81. Ghosh A, Muthuraju S, Badal S, et al. Differential expression of presynaptic Munc13-1 and Munc13-2 in mouse hippocampus following ethanol drinking. Neuroscience. 2022;487:166–183. doi:10.1016/j.neuroscience.2022.02.008

82. Hansen AW, Almeida FB, Bandiera S, et al. Correlations between subunits of GABAA and NMDA receptors after chronic alcohol treatment or withdrawal, and the effect of taurine in the hippocampus of rats. Alcohol. 2020;82:63–70. doi:10.1016/j.alcohol.2019.08.005

83. Chandler LJ, Norwood D, Sutton G. Chronic ethanol upregulates NMDA and AMPA, but not kainate receptor subunit proteins in rat primary cortical cultures. Alcoholism. 1999;23(2):363–370. doi:10.1111/j.1530-0277.1999.tb04123.x

84. Patel KT, Stevens MC, Dunlap A, et al. Effects of the Fyn kinase inhibitor saracatinib on ventral striatal activity during performance of an fMRI monetary incentive delay task in individuals family history positive or negative for alcohol use disorder. A pilot randomised trial. Neuropsychopharmacology. 2022;47(4):840–846. doi:10.1038/s41386-021-01157-5

85. Morisot N, Ron D. Alcohol-dependent molecular adaptations of the NMDA receptor system. Genes Brain Behav. 2017;16(1):139–148. doi:10.1111/gbb.12363

86. Li Q, Wilson WA, Swartzwelder HS. Differential effect of ethanol on NMDA EPSCs in pyramidal cells in the posterior cingulate cortex of juvenile and adult rats. J Neurophysiol. 2002;87(2):705–711. doi:10.1152/jn.00433.2001

87. Hermann D, Weber-Fahr W, Sartorius A, et al. Translational magnetic resonance spectroscopy reveals excessive central glutamate levels during alcohol withdrawal in humans and rats. Biol Psychiatry. 2012;71(11):1015–1021. doi:10.1016/j.biopsych.2011.07.034

88. Brousse G, Arnaud B, Vorspan F, et al. Alteration of glutamate/GABA balance during acute alcohol withdrawal in emergency department: a prospective analysis. Alcohol Alcohol. 2012;47(5):501–508. doi:10.1093/alcalc/ags078

89. Knapp DJ, Overstreet DH, Breese GR. Baclofen blocks expression and sensitization of anxiety-like behavior in an animal model of repeated stress and ethanol withdrawal. Alcoholism. 2007;31(4):582–595. doi:10.1111/j.1530-0277.2007.00342.x

90. Nelson TE, Ur CL, Gruol DL. Chronic intermittent ethanol exposure enhances NMDA-receptor-mediated synaptic responses and NMDA receptor expression in hippocampal CA1 region. Brain Res. 2005;1048(1–2):69–79. doi:10.1016/j.brainres.2005.04.041

91. Darstein MB, Landwehrmeyer GB, Feuerstein TJ. Changes in NMDA receptor subunit gene expression in the rat brain following withdrawal from forced long-term ethanol intake. Naunyn-Schmiedeberg’s Arch Pharmacol. 2000;361(2):206–213. doi:10.1007/s002109900180

92. Wang D, Zhu T, Chen J, Lu Y, Zhou C, Chang Y-K. Acute aerobic exercise ameliorates cravings and inhibitory control in heroin addicts: evidence from event-related potentials and frequency bands. Frontiers in Psychology. 2020;11:561590. doi:10.3389/fpsyg.2020.561590

93. Smethells JR, Greer A, Dougen B, Carroll ME. Effects of voluntary exercise and sex on multiply-triggered heroin reinstatement in male and female rats. Psychopharmacology. 2020;237(2):453–463. doi:10.1007/s00213-019-05381-2

94. Thanos PK, Tucci A, Stamos J, et al. Chronic forced exercise during adolescence decreases cocaine conditioned place preference in Lewis rats. Behav Brain Res. 2010;215(1):77–82. doi:10.1016/j.bbr.2010.06.033

95. Abdullah M, Huang L-C, Lin S-H, Yang YK. Dopaminergic and glutamatergic biomarkers disruption in addiction and regulation by exercise: a mini review. Biomarkers. 2022;27(4):306–318. doi:10.1080/1354750X.2022.2049367

96. Thanos PK, Stamos J, Robison LS, et al. Daily treadmill exercise attenuates cocaine cue-induced reinstatement and cocaine induced locomotor response but increases cocaine-primed reinstatement. Behav Brain Res. 2013;239:8–14. doi:10.1016/j.bbr.2012.10.035

97. Paushter RL. Exploring the Role of Physical Activity in Recovery from Substance Use Disorder Among Adults: A Systematic Review [M.S.W.]. United States – California: San Diego State University; 2021.

98. Ashdown-Franks G, Firth J, Carney R, et al. Exercise as medicine for mental and substance use disorders: a meta-review of the benefits for neuropsychiatric and cognitive outcomes. Sports Med. 2020;50(1):151–170. doi:10.1007/s40279-019-01187-6

99. Cabral DA, Tavares VD, da Costa KG, et al. The benefits of high intensity exercise on the brain of a drug abuser. Global J Health Sci. 2018;10(6):123. doi:10.5539/gjhs.v10n6p123

100. Kraemer RR, Kraemer BR. The effects of peripheral hormone responses to exercise on adult hippocampal neurogenesis. Front Endocrinol. 2023;14:1202349. doi:10.3389/fendo.2023.1202349

101. Petrella C, Farioli-Vecchioli S, Cisale GY, et al. A healthy gut for a healthy brain: preclinical, clinical and regulatory aspects. Curr Neuropharmacol. 2021;19(5):610–628. doi:10.2174/1570159X18666200730111528

102. Heijnen S, Hommel B, Kibele A, Colzato LS. Neuromodulation of aerobic exercise—a review. Front Psychol. 2016;6. doi:10.3389/fpsyg.2015.01890

103. Matta mello portugal E, Cevada T, Sobral Monteiro-Junior R, et al. Neuroscience of exercise: from neurobiology mechanisms to mental health. Neuropsychobiology. 2013;68(1):1–14. doi:10.1159/000350946

104. Hallgren M, Vancampfort D, Giesen ES, Lundin A, Stubbs B. Exercise as treatment for alcohol use disorders: systematic review and meta-analysis. Br J Sports Med. 2017;51(14):1058–1064. doi:10.1136/bjsports-2016-096814

105. Gunillasdotter V. Effects of exercise on alcohol use disorders; 2022.

106. West RK, Najjar LZ, Leasure JL. Chapter Nine - Exercise-driven restoration of the alcohol-damaged brain. In: Yau S-Y, So K-F, editors. International Review of Neurobiology. Vol. 147. Academic Press; 2019:219–267.

107. West RK, Wooden JI, Barton EA, Leasure JL. Recurrent binge ethanol is associated with significant loss of dentate gyrus granule neurons in female rats despite concomitant increase in neurogenesis. Neuropharmacology. 2019;148:272–283. doi:10.1016/j.neuropharm.2019.01.016

108. Goodman J, Leong K-C, Packard MG. NMDA Receptor blockade in the dorsolateral striatum impairs consolidation but not retrieval of habit memory. Neurobiol Learn Mem. 2022;197:107709. doi:10.1016/j.nlm.2022.107709

109. Goodman J. Place vs. response learning: history, controversy, and neurobiology. Front Behav Neurosci. 2021;14:598570. doi:10.3389/fnbeh.2020.598570

110. Joyce J. Exploring the pathophysiology of persistent post-concussive symptoms and metabolite response to an aerobic exercise treatment intervention; 2022.

111. Shi K, Liu X, Hou L, Qiao D, Lin X. Effects of exercise on mGluR-mediated glutamatergic transmission in the striatum of hemiparkinsonian rats. Neurosci Lett. 2019;705:143–150. doi:10.1016/j.neulet.2019.04.052

112. Loprinzi PD. The effects of exercise on long-term potentiation: a candidate mechanism of the exercise-memory relationship. OBM Neurobiol. 2019;3(2):1. doi:10.21926/obm.neurobiol.1902026

113. Moore D, Loprinzi PD. Exercise influences episodic memory via changes in hippocampal neurocircuitry and long-term potentiation. Eur J Neurosci. 2021;54(8):6960–6971. doi:10.1111/ejn.14728

114. Li C, Liu T, Li R, Zhou C. Effects of exercise on proactive interference in memory: potential neuroplasticity and neurochemical mechanisms. Psychopharmacology. 2020;237(7):1917–1929. doi:10.1007/s00213-020-05554-4

115. Wu Y, Deng F, Wang J, et al. Intensity-dependent effects of consecutive treadmill exercise on spatial learning and memory through the p-CREB/BDNF/NMDAR signaling in hippocampus. Behav Brain Res. 2020;386:112599. doi:10.1016/j.bbr.2020.112599

116. Rahman N, Mihalkovic A, Geary O, Haffey R, Hamilton J, Thanos PK. Chronic aerobic exercise: autoradiographic assessment of GABA(a) and mu-opioid receptor binding in adult rats. Pharmacol Biochem Behav. 2020;196:172980. doi:10.1016/j.pbb.2020.172980

117. Robison LS, Swenson S, Hamilton J, Thanos PK. Exercise reduces dopamine D1R and increases D2R in rats: implications for addiction. Med Sci Sports Exercise. 2018;50(8):1596–1602. doi:10.1249/MSS.0000000000001627

118. Swenson S, Hamilton J, Robison L, Thanos PK. Chronic aerobic exercise: lack of effect on brain CB1 receptor levels in adult rats. Life Sci. 2019;230:84–88. doi:10.1016/j.lfs.2019.05.058

119. Vecchio LM, Meng Y, Xhima K, Lipsman N, Hamani C, Aubert I. The neuroprotective effects of exercise: maintaining a healthy brain throughout aging. Brain Plast. 2018;4(1):17–52. doi:10.3233/BPL-180069

120. Reus VI, Fochtmann LJ, Bukstein O, et al. The American Psychiatric Association Practice Guideline for the pharmacological treatment of patients with alcohol use disorder. Am J Psychiatry. 2018;175(1):86–90. doi:10.1176/appi.ajp.2017.1750101

121. Giesen ES, Deimel H, Bloch W. Clinical exercise interventions in alcohol use disorders: a systematic review. J Subst Abuse Treat. 2015;52:1–9. doi:10.1016/j.jsat.2014.12.001

122. Vetreno RP, Lawrimore CJ, Rowsey PJ, Crews FT. Persistent adult neuroimmune activation and loss of hippocampal neurogenesis following adolescent ethanol exposure: blockade by exercise and the anti-inflammatory drug indomethacin. Front Neurosci. 2018;12:200. doi:10.3389/fnins.2018.00200

123. Hunsberger J, Austin DR, Henter ID, Chen G. The neurotrophic and neuroprotective effects of psychotropic agents. Dialogues Clin Neurosci. 2022;11(3):333–348.

124. de Almeida AA, Gomes da Silva S, Lopim GM, et al. Resistance exercise reduces seizure occurrence, attenuates memory deficits and restores BDNF signaling in rats with chronic epilepsy. Neurochem Res. 2017;42(4):1230–1239. doi:10.1007/s11064-016-2165-9

125. Fan B, Jabeen R, Bo B, et al. What and how can physical activity prevention function on Parkinson’s disease? Oxid Med Cell Longev. 2020;2020:1–12. doi:10.1155/2020/4293071

126. Di Raimondo D, Rizzo G, Musiari G, Tuttolomondo A, Pinto A. Role of regular physical activity in neuroprotection against acute ischemia. Int J Mol Sci. 2020;21(23):9086. doi:10.3390/ijms21239086

127. Alkadhi KA. Exercise as a positive modulator of brain function. Mol Neurobiol. 2018;55(4):3112–3130. doi:10.1007/s12035-017-0516-4

128. Yuwong Wanyu B, Emégam Kouémou N, Sotoing Taiwe G, et al. Dichrocephala integrifolia aqueous extract antagonises chronic and binges ethanol feeding-induced memory dysfunctions: insights into antioxidant and anti-inflammatory mechanisms. Evid Based Complement Alternat Med. 2022;2022:1–12. doi:10.1155/2022/1620816

129. Sawchuk SD, Reid HM, Neale KJ, Shin J, Christie BR, Nixon K. Effects of ethanol on synaptic plasticity and NMDA currents in the juvenile rat dentate gyrus. Brain Plast. 2020;6(1):123–136. doi:10.3233/BPL-200110

130. Morisot N, Berger AL, Phamluong K, Cross A, Ron D. The Fyn kinase inhibitor, AZD0530, suppresses mouse alcohol self‐administration and seeking. Addict Biol. 2019;24(6):1227–1234. doi:10.1111/adb.12699

131. Stratilov VA, Tyulkova EI, Vetrovoy OV. Prenatal stress as a factor of the development of addictive states. J Evolut Biochem Physiol. 2020;56(6):471–490. doi:10.1134/S0022093020060010

132. Abrahao KP, Salinas AG, Lovinger DM. Alcohol and the brain: neuronal molecular targets, synapses, and circuits. Neuron. 2017;96(6):1223–1238. doi:10.1016/j.neuron.2017.10.032

133. Haque M, Koski KG, Scott ME. Maternal gastrointestinal nematode infection up-regulates expression of genes associated with long-term potentiation in perinatal brains of uninfected developing pups. Sci Rep. 2019;9(1):1–15. doi:10.1038/s41598-019-40729-w

134. Lahvis GP. Unbridle biomedical research from the laboratory cage. eLife. 2017;6. doi:10.7554/eLife.27438

135. Shillinglaw JE. Synaptic effects of ethanol on the agranular insunlar cortex; 2019.

136. Rowland JA, Stapleton-Kotloski JR, Alberto GE, et al. Changes in nonhuman primate brain function following chronic alcohol consumption in previously naïve animals. Drug Alcohol Depend. 2017;177:244–248. doi:10.1016/j.drugalcdep.2017.03.036

137. Roberto M, Varodayan FP. Synaptic targets: chronic alcohol actions. Neuropharmacology. 2017;122:85–99. doi:10.1016/j.neuropharm.2017.01.013

138. Wegner SA, Hu B, De Oliveira Sergio T, et al. A novel NMDA receptor-based intervention to suppress compulsion-like alcohol drinking. Neuropharmacology. 2019;157:107681. doi:10.1016/j.neuropharm.2019.107681

139. de Oliveira Souza IN, Roychaudhuri R, De Belleroche J, Mothet J-P. d-Amino acids: new clinical pathways for brain diseases. Trends Mol Med. 2023;29(12):1014–1028. doi:10.1016/j.molmed.2023.09.001

140. De Oliveira Sergio T, Frasier RM, Hopf FW. Animal models of compulsion alcohol drinking: why we love quinine-resistant intake and what we learned from it. Front Psychiatry. 2023;14. doi:10.3389/fpsyt.2023.1116901

141. Wang Y. The role of endoplasmic reticulum stress in ethanol-induced neurodegeneration; 2019.

142. Loheswaran G. Alcohol Effects on Human Neurophysiology. Canada: University of Toronto; 2017.

143. Bandiera S, Almeida FB, Hansen AW, et al. Combined use of alcohol and cigarette increases locomotion and glutamate levels in the cerebrospinal fluid without changes on GABAA or NMDA receptor subunit mRNA expression in the hippocampus of rats. Behav Brain Res. 2020;380:112444. doi:10.1016/j.bbr.2019.112444

144. Solomon MG. Role of BDNF in the ability of exercise to attenuate dependence-related escalated alcohol drinking in C57BL/6J mice; 2019.

145. Hsieh C-P, Chang W-T, Chen L, Chen -H-H, Chan M-H. Differential inhibitory effects of resveratrol on excitotoxicity and synaptic plasticity: involvement of NMDA receptor subtypes. Nutr Neurosci. 2021;24(6):443–458. doi:10.1080/1028415X.2019.1641995

146. Ahnaou A, Heleven K, Biermans R, Manyakov NV, Drinkenburg WH. NMDARs containing NR2B subunit do not contribute to the LTP form of hippocampal plasticity: in vivo pharmacological evidence in rats. Int J Mol Sci. 2021;22(16):8672. doi:10.3390/ijms22168672

147. Blum K, Han D, Bowirrat A, et al. Genetic addiction risk and psychological profiling analyses for “Preaddiction” Severity Index. J Pers Med. 2022;12(11):1772.

148. Blum K, Thanos PK, Gold MS. Dopamine and glucose, obesity, and reward deficiency syndrome. Front Psychol. 2014;5:919. doi:10.3389/fpsyg.2014.00919

149. Kalivas PW. The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci. 2009;10(8):561–572. doi:10.1038/nrn2515

150. Volkow ND, Michaelides M, Baler R. The neuroscience of drug reward and addiction. Physiol Rev. 2019;99(4):2115–2140. doi:10.1152/physrev.00014.2018

151. Skeberdis VA, Lan J, Zheng X, Zukin RS, Bennett MV. Insulin promotes rapid delivery of N-methyl-D- aspartate receptors to the cell surface by exocytosis. Proc Natl Acad Sci U S A. 2001;98(6):3561–3566. doi:10.1073/pnas.051634698

152. Christie JM, Wenthold RJ, Monaghan DT. Insulin causes a transient tyrosine phosphorylation of NR2A and NR2B NMDA receptor subunits in rat hippocampus. J Neurochem. 1999;72(4):1523–1528. doi:10.1046/j.1471-4159.1999.721523.x

153. Meijerink WJ, Molina PE, Lang CH, Abumrad NN. Contribution of excitatory amino acids to morphine-induced metabolic alterations. Brain Res. 1996;706(1):123–128. doi:10.1016/0006-8993(95)01205-2

154. Chen PY, Cui Z, Lee LF, Witter RL. Serologic differences among nondefective reticuloendotheliosis viruses. Arch Virol. 1987;93(3–4):233–245. doi:10.1007/BF01310977

155. Rasineni K, Thomes PG, Kubik JL, Harris EN, Kharbanda KK, Casey CA. Chronic alcohol exposure alters circulating insulin and ghrelin levels: role of ghrelin in hepatic steatosis. Am J Physiol Gastrointest Liver Physiol. 2019;316(4):G453–G461. doi:10.1152/ajpgi.00334.2018

156. Huang XT, Yang JX, Wang Z, et al. Activation of N-methyl-D-aspartate receptor regulates insulin sensitivity and lipid metabolism. Theranostics. 2021;11(5):2247–2262. doi:10.7150/thno.51666

157. Malin SK, Stewart NR, Ude AA, Alderman BL. Brain insulin resistance and cognitive function: influence of exercise. J Appl Physiol. 2022;133(6):1368–1380. doi:10.1152/japplphysiol.00375.2022

158. Centanni SW, Conley SY, Luchsinger JR, Lantier L, Winder DG. The impact of intermittent exercise on mouse ethanol drinking and abstinence-associated affective behavior and physiology. Alcohol Clin Exp Res. 2022;46(1):114–128. doi:10.1111/acer.14742

Creative Commons License © 2024 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.